We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Reusable ECG Patch Analyzes Human Vitals and Biometrics

By HospiMedica International staff writers
Posted on 17 Dec 2019
A novel wearable electrocardiogram (ECG) patch combines multiple vitals and biometrics into a single platform for continuous patient monitoring.

Weighing just 7.5 grams, the VivaLNK (Campbell, CA, USA) Multi-Vital ECG Patch can generate a continuous stream of ECG rhythm, respiratory rate (RR), RR interval, heart rate, and three-axis accelerometer data for continuous patient and remote patient monitoring (RPM) applications. More...
The patient-centric sensor, which comes in the form of a small bandage, is reusable, which can increase its economic value ten-fold or more, compared to single use devices. An associated Software Development Kit (SDK) enables application developers to build medical solutions, without needing to become experts in hardware and sensor networks.

Application of the patch include live streaming and offline recording of ECG traces; cardiac arrhythmia monitoring; chemotherapy remote patient monitoring; clinical trial remote patient monitoring; patient infection monitoring; hypertension stress management; and heart failure event detection. The SDK is part of the VivaLNK Medical Sensor Platform strategy, which accelerates medical application innovation by decoupling the sensor hardware, data capture in remote locations, and cloud connectivity from the application, so that healthcare solution developers can focus on the algorithms and analytics for their specific domain.

“Our aim is to accelerate medical application development by providing the sensor platform so that the industry can rapidly innovate novel solutions, while at the same time making it more accessible to patients around the world,” said Jiang Li, CEO of VivaLNK. “VivaLNK's unique electronic skin technology offers powerful technical capabilities without compromising user experience.”

As a result of increasing healthcare costs, an increasing aging population, and demonstrated improved patient outcomes with advanced RPM technologies, healthcare providers are beginning to shift eligible patients toward home care programs. Remote and continuous monitoring have shown a reduction in readmissions, improved patient outcomes, and overall decrease in cost of care compared to a traditional hospital stay.

Related Links:
VivaLNK


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Infusion System
SIGMA Spectrum
New
Mattress System
Apollo Infant Dynamic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.